These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 15520004

  • 1. Distinct molecular mechanisms for agonist peptide binding to types A and B cholecystokinin receptors demonstrated using fluorescence spectroscopy.
    Harikumar KG, Clain J, Pinon DI, Dong M, Miller LJ.
    J Biol Chem; 2005 Jan 14; 280(2):1044-50. PubMed ID: 15520004
    [Abstract] [Full Text] [Related]

  • 2. Environment and mobility of a series of fluorescent reporters at the amino terminus of structurally related peptide agonists and antagonists bound to the cholecystokinin receptor.
    Harikumar KG, Pinon DI, Wessels WS, Prendergast FG, Miller LJ.
    J Biol Chem; 2002 May 24; 277(21):18552-60. PubMed ID: 11893747
    [Abstract] [Full Text] [Related]

  • 3. Fluorescence resonance energy transfer analysis of the antagonist- and partial agonist-occupied states of the cholecystokinin receptor.
    Harikumar KG, Miller LJ.
    J Biol Chem; 2005 May 13; 280(19):18631-5. PubMed ID: 15757907
    [Abstract] [Full Text] [Related]

  • 4. Use of probes with fluorescence indicator distributed throughout the pharmacophore to examine the peptide agonist-binding environment of the family B G protein-coupled secretin receptor.
    Harikumar KG, Hosohata K, Pinon DI, Miller LJ.
    J Biol Chem; 2006 Feb 03; 281(5):2543-50. PubMed ID: 16319066
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Measurement of intermolecular distances for the natural agonist Peptide docked at the cholecystokinin receptor expressed in situ using fluorescence resonance energy transfer.
    Harikumar KG, Pinon DI, Wessels WS, Dawson ES, Lybrand TP, Prendergast FG, Miller LJ.
    Mol Pharmacol; 2004 Jan 03; 65(1):28-35. PubMed ID: 14722234
    [Abstract] [Full Text] [Related]

  • 9. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
    Boteju LW, Nikiforovich GV, Haskell-Luevano C, Fang SN, Zalewska T, Stropova D, Yamamura HI, Hruby VJ.
    J Med Chem; 1996 Sep 27; 39(20):4120-4. PubMed ID: 8831778
    [Abstract] [Full Text] [Related]

  • 10. Use of Fluorescence Indicators in Receptor Ligands.
    Harikumar KG, Miller LJ.
    Methods Mol Biol; 2015 Sep 27; 1335():115-30. PubMed ID: 26260598
    [Abstract] [Full Text] [Related]

  • 11. Key differences in molecular complexes of the cholecystokinin receptor with structurally related peptide agonist, partial agonist, and antagonist.
    Arlander SJ, Dong M, Ding XQ, Pinon DI, Miller LJ.
    Mol Pharmacol; 2004 Sep 27; 66(3):545-52. PubMed ID: 15322246
    [Abstract] [Full Text] [Related]

  • 12. Structurally related peptide agonist, partial agonist, and antagonist occupy a similar binding pocket within the cholecystokinin receptor. Rapid analysis using fluorescent photoaffinity labeling probes and capillary electrophoresis.
    Dong M, Ding XQ, Pinon DI, Hadac EM, Oda RP, Landers JP, Miller LJ.
    J Biol Chem; 1999 Feb 19; 274(8):4778-85. PubMed ID: 9988716
    [Abstract] [Full Text] [Related]

  • 13. Direct identification of a second distinct site of contact between cholecystokinin and its receptor.
    Hadac EM, Pinon DI, Ji Z, Holicky EL, Henne RM, Lybrand TP, Miller LJ.
    J Biol Chem; 1998 May 22; 273(21):12988-93. PubMed ID: 9582333
    [Abstract] [Full Text] [Related]

  • 14. The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor. Evidence for a crucial role of Met-121 in the activation process.
    Escrieut C, Gigoux V, Archer E, Verrier S, Maigret B, Behrendt R, Moroder L, Bignon E, Silvente-Poirot S, Pradayrol L, Fourmy D.
    J Biol Chem; 2002 Mar 01; 277(9):7546-55. PubMed ID: 11724786
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.